Can a G-tube (gastrostomy tube) cause Staphylococcus bacteremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can G-Tubes Cause Staphylococcus Bacteremia?

Yes, G-tubes can cause Staphylococcus bacteremia, though this is an uncommon complication—staphylococci are the most frequently isolated organisms in gastrostomy tube infections, and while most infections remain localized to the stoma site, bacteremia can occur particularly when site infections are inadequately treated or when there is associated peritonitis or deep abscess formation. 1, 2

Infection Risk and Microbiology

  • Gastrostomy tube site infections occur in approximately 15% of cases after transoral placement, with an overall infection rate of 4.8% documented in community hospital settings 3, 1
  • Staphylococci (both coagulase-positive and coagulase-negative) are the most common infecting organisms at G-tube sites, followed by gram-negative bacteria and yeast 1
  • Methicillin-resistant Staphylococcus aureus (MRSA) poses particular risk: patients with known prior MRSA colonization have a 57% chance of developing symptomatic MRSA infection at the PEG site, while those without known colonization still face a 15% risk 2

Progression from Local to Systemic Infection

  • Most G-tube infections remain localized to the stoma site and do not progress to bacteremia when treated appropriately 4, 1
  • Serious systemic infections occurred in only 4 of 372 cases (1.1%) in one series, including two cases of peritonitis and two deep abscesses, but no infectious deaths 1
  • The key risk for bacteremia development is inadequate or delayed treatment of the local site infection, allowing progression to deeper tissue involvement 1, 5

High-Risk Scenarios for Bacteremia

  • Patients with diabetes, obesity, poor nutritional status, chronic corticosteroid therapy, or other immunosuppressive conditions face elevated risk of both local infection and systemic spread 4, 3
  • Excessive tension between internal and external bolsters can cause tissue necrosis and create a portal for bacterial invasion into the bloodstream 6, 4
  • Stoma tract disruption or buried bumper syndrome may allow direct bacterial access to deeper tissues and vasculature 6

Recognition and Management Algorithm

Initial Assessment

  • Examine the stoma site daily for erythema, purulent or malodorous drainage, fever, and pain—these indicate infection requiring immediate intervention 4, 3
  • Swab the area for both bacterial and fungal cultures before starting antimicrobial therapy to guide targeted treatment 6, 4
  • Ensure the external bolster has approximately 1 cm of play—excessive tightness increases infection risk 4, 3

Treatment Escalation

  • Start with topical antimicrobial agents applied to the entry site and surrounding tissue 4, 7
  • If infection persists after 5-7 days of topical treatment, add oral broad-spectrum antibiotics 4, 7
  • For signs of systemic infection (fever, elevated white count, hypotension), immediately initiate intravenous broad-spectrum antibiotics and obtain blood cultures 4, 5

Source Control

  • If bacteremia is confirmed with S. aureus, the G-tube must be removed and replaced at a different site—catheter retention in S. aureus bacteremia is associated with increased mortality and metastatic complications 5
  • For uncomplicated S. aureus bacteremia after catheter removal, treat with 10-14 days of intravenous antibiotics (cefazolin or antistaphylococcal penicillin for MSSA; vancomycin or daptomycin for MRSA) 6, 5
  • Prolonged bacteremia (≥48 hours) carries a 39% 90-day mortality risk and mandates echocardiography to evaluate for endocarditis 5

Critical Pitfalls to Avoid

  • Never dismiss minor erythema or drainage as "normal"—early aggressive treatment of local infection prevents progression to bacteremia 1
  • Do not use topical antibiotics, as they promote resistance; use antimicrobial ointments or sustained-release dressings instead 6, 4
  • Failure to remove the G-tube in confirmed S. aureus bacteremia significantly increases risk of endocarditis, metastatic infection, and death 5
  • In patients with prosthetic heart valves or recurrent bacteremia, even without meeting strict endocarditis criteria, maintain high clinical suspicion and consider transesophageal echocardiography 8

References

Research

Gastrostomy tube infections in a community hospital.

American journal of infection control, 1996

Guideline

Treatment of PEG Tube Site Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Stoma Site Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Red-Greenish Drainage from G-Tube Site

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Staphylococcus aureus bacteremia caused by infected intravenous catheters.

American journal of infection control, 1987

Related Questions

What is the appropriate treatment for a 48-year-old patient with a hand skin infection caused by Methicillin (Oxacillin) Resistant Staphylococcus aureus (MRSA) and Beta Hemolytic Streptococcus Group G, who has been previously treated with Bactrim (Sulfamethoxazole/Trimethoprim), Keflex (Cephalexin), and Clindamycin?
What is the treatment for a 55-year-old male with a computed tomography (CT) scan of the face showing a 3mm periosteal abscess with cellulitis?
What is the best approach for a 78-year-old male with Staphylococcus haemolyticus bacteremia on vancomycin (Vancomycin) and right toe cellulitis with possible fungal involvement on Ambisome (Amphotericin B)/Voriconazole (Voriconazole), considering the role of imaging and beta-D-glucan as a biomarker?
What is the best empiric antibiotic therapy for a 21-month-old girl with suspected epiglottitis (inflammation of the epiglottis), presenting with dysphagia (difficulty swallowing), tachypnea (rapid breathing), tachycardia (rapid heart rate), fever, stridor, and impending respiratory failure?
How should a patient with new fevers, rash, facial swelling, and positive Methicillin-resistant Staphylococcus epidermidis (MRSE) blood cultures be treated?
Can someone with a povidone allergy take Tamiflu (oseltamivir)?
Are Schüssler Salze (homeopathic remedies) effective and safe for treating medical conditions?
What dose adjustment is needed for azithromycin in a patient with severe renal impairment?
What is the best anti-inflammatory for a patient with coxitis, psoriatic arthritis (PsA), and systemic sclerosis?
What is the differential diagnosis and initial management for a patient presenting with symptoms suggestive of an internal ear abscess?
Is an alternative medicinal preparation based on ash safe and effective for treatment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.